Operator
Good morning, everyone, and welcome to the MediWound’s Third Quarter 2025 Earnings Call. [Operator Instructions] Please also note today’s event is being recorded. And at this time, I’d like to turn the floor over to Dan Ferry of LifeSci Advisors. Please go ahead.
Daniel Ferry
Lifesci Advisors, LLC
Thank you, operator, and welcome, everyone. Earlier today, pre-market opened, MediWound issued a press release announcing financial results for the third quarter ended September 30, 2025. You may access this press release on the company’s website under the Investors tab. I would ask you to review the full text of our forward-looking statements within this morning’s press release.
Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session, relating to MediWound’s expected future performance, future business prospects or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. These statements may involve risks and uncertainties that could cause actual results to differ materially from expectations and are described more fully in our filings with the SEC. In addition, all forward-looking statements represent our views only as of today, and MediWound assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events or otherwise.
This conference call is the
